Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet need after progression or intolerance. A 30-patient, 15-center JCOG study ...

Angiosarcoma of the gastrointestinal tract is an exceedingly rare and aggressive vascular tumour that arises from the endothelial cells lining blood vessels. Although primary angiosarcoma in this ...

Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...

“[...] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.” “In our ...

The Alliance AO91902 trial investigated whether adding immunotherapy to chemotherapy would improve outcomes for patients with advanced angiosarcoma. Although immunotherapy has become a mainstay of ...

Epidemiological trends and socioeconomic factors in malignant peripheral nerve sheath tumors with rhabdomyoblastic differentiation: A National Cancer Database study. This is an ASCO Meeting Abstract ...